Go Pro

Precision Optics (POCI) Competitors

Precision Optics logo
$4.45 -0.01 (-0.22%)
As of 09/21/2026 04:00 PM Eastern

POCI vs. FOCL, ZJYL, CNXU, KRMD, and INGN

Should you buy Precision Optics stock or one of its competitors? Precision Optics's main competitors and comparable companies include FocalTherics (FOCL), Jin Medical International (ZJYL), Conexeu Sciences (CNXU), KORU Medical Systems (KRMD), and Inogen (INGN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Precision Optics compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Precision Optics (NASDAQ:POCI) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

FocalTherics presently has a consensus target price of $7.75, indicating a potential upside of 82.78%. Given FocalTherics' stronger consensus rating and higher possible upside, equities research analysts plainly believe FocalTherics is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FocalTherics
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.40
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Precision Optics has lower revenue, but higher earnings than FocalTherics. Precision Optics is trading at a lower price-to-earnings ratio than FocalTherics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FocalTherics$70.53M2.26-$29.25M-$1.03N/A
Precision Optics$19.09M2.55-$5.78M-$0.63N/A

In the previous week, Precision Optics had 3 more articles in the media than FocalTherics. MarketBeat recorded 3 mentions for Precision Optics and 0 mentions for FocalTherics. FocalTherics' average media sentiment score of 0.00 equaled Precision Optics'average media sentiment score.

Company Overall Sentiment
FocalTherics Neutral
Precision Optics Neutral

FocalTherics has a beta of -0.07, meaning that its share price is 107% less volatile than the broader market. Comparatively, Precision Optics has a beta of 0.32, meaning that its share price is 68% less volatile than the broader market.

Precision Optics has a net margin of -17.03% compared to FocalTherics' net margin of -56.26%. Precision Optics' return on equity of -37.47% beat FocalTherics' return on equity.

Company Net Margins Return on Equity Return on Assets
FocalTherics-56.26% -248.00% -44.69%
Precision Optics -17.03%-37.47%-19.96%

62.7% of FocalTherics shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 10.1% of FocalTherics shares are owned by company insiders. Comparatively, 14.4% of Precision Optics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Precision Optics beats FocalTherics on 9 of the 16 factors compared between the two stocks.

How does Precision Optics compare to Jin Medical International?

Precision Optics (NASDAQ:POCI) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

In the previous week, Precision Optics had 3 more articles in the media than Jin Medical International. MarketBeat recorded 3 mentions for Precision Optics and 0 mentions for Jin Medical International. Precision Optics' average media sentiment score of 0.00 equaled Jin Medical International'saverage media sentiment score.

Company Overall Sentiment
Precision Optics Neutral
Jin Medical International Neutral

13.7% of Precision Optics shares are owned by institutional investors. 14.4% of Precision Optics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Jin Medical International has higher revenue and earnings than Precision Optics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$19.09M2.55-$5.78M-$0.63N/A
Jin Medical International$20.69M7.85$1.19MN/AN/A

Precision Optics has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.31, indicating that its stock price is 631% more volatile than the broader market.

Jin Medical International has a net margin of 0.00% compared to Precision Optics' net margin of -17.03%. Jin Medical International's return on equity of 0.00% beat Precision Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-17.03% -37.47% -19.96%
Jin Medical International N/A N/A N/A

Summary

Jin Medical International beats Precision Optics on 7 of the 10 factors compared between the two stocks.

How does Precision Optics compare to Conexeu Sciences?

Precision Optics (NASDAQ:POCI) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk and earnings.

Conexeu Sciences has a consensus price target of $20.00, indicating a potential upside of 321.05%. Given Conexeu Sciences' stronger consensus rating and higher possible upside, analysts plainly believe Conexeu Sciences is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Conexeu Sciences
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

13.7% of Precision Optics shares are held by institutional investors. 14.4% of Precision Optics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Conexeu Sciences has a net margin of 0.00% compared to Precision Optics' net margin of -17.03%. Precision Optics' return on equity of -37.47% beat Conexeu Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-17.03% -37.47% -19.96%
Conexeu Sciences N/A -200.20%-177.26%

In the previous week, Precision Optics had 2 more articles in the media than Conexeu Sciences. MarketBeat recorded 3 mentions for Precision Optics and 1 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.97 beat Precision Optics' score of 0.00 indicating that Conexeu Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precision Optics
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Conexeu Sciences
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Conexeu Sciences has lower revenue, but higher earnings than Precision Optics. Conexeu Sciences is trading at a lower price-to-earnings ratio than Precision Optics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$19.09M2.55-$5.78M-$0.63N/A
Conexeu SciencesN/AN/A-$3.92M-$0.11N/A

Summary

Precision Optics and Conexeu Sciences tied by winning 7 of the 14 factors compared between the two stocks.

How does Precision Optics compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Precision Optics (NASDAQ:POCI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market. Comparatively, Precision Optics has a beta of 0.32, suggesting that its stock price is 68% less volatile than the broader market.

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Comparatively, 14.4% of Precision Optics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Precision Optics had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 3 mentions for Precision Optics and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.34 beat Precision Optics' score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Precision Optics
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

KORU Medical Systems currently has a consensus price target of $7.00, suggesting a potential upside of 116.72%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, equities research analysts plainly believe KORU Medical Systems is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

KORU Medical Systems has a net margin of -4.03% compared to Precision Optics' net margin of -17.03%. KORU Medical Systems' return on equity of -10.63% beat Precision Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-4.03% -10.63% -6.51%
Precision Optics -17.03%-37.47%-19.96%

KORU Medical Systems has higher revenue and earnings than Precision Optics. KORU Medical Systems is trading at a lower price-to-earnings ratio than Precision Optics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M3.61-$2.64M-$0.04N/A
Precision Optics$19.09M2.55-$5.78M-$0.63N/A

Summary

KORU Medical Systems beats Precision Optics on 14 of the 16 factors compared between the two stocks.

How does Precision Optics compare to Inogen?

Precision Optics (NASDAQ:POCI) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

In the previous week, Precision Optics had 2 more articles in the media than Inogen. MarketBeat recorded 3 mentions for Precision Optics and 1 mentions for Inogen. Precision Optics' average media sentiment score of 0.00 equaled Inogen'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precision Optics
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inogen
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Inogen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50

Inogen has a net margin of -6.94% compared to Precision Optics' net margin of -17.03%. Inogen's return on equity of -13.17% beat Precision Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-17.03% -37.47% -19.96%
Inogen -6.94%-13.17%-8.36%

Precision Optics has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market. Comparatively, Inogen has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

Precision Optics has higher earnings, but lower revenue than Inogen. Precision Optics is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$19.09M2.55-$5.78M-$0.63N/A
Inogen$354.30M0.38-$22.75M-$0.90N/A

13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 89.9% of Inogen shares are owned by institutional investors. 14.4% of Precision Optics shares are owned by company insiders. Comparatively, 2.5% of Inogen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Inogen beats Precision Optics on 9 of the 14 factors compared between the two stocks.

Get Precision Optics News Delivered to You Automatically

Sign up to receive the latest news and ratings for POCI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding POCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

POCI vs. The Competition

MetricPrecision OpticsHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$48.81M$5.54B$7.25B$12.97B
Dividend YieldN/A1.80%2.53%12.80%
P/E Ratio-7.0625.31274.7125.77
Price / Sales2.5572.07696.46110.29
Price / CashN/A33.1128.0434.72
Price / Book2.785.8810.566.36
Net Income-$5.78M$151.55M$3.49B$358.17M
7 Day Performance5.70%0.97%0.80%1.60%
1 Month Performance-2.41%-3.90%-2.80%-2.97%
1 Year Performance-2.52%5.90%16.68%5.63%

Precision Optics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POCI
Precision Optics
0.5165 of 5 stars
$4.45
-0.2%
N/A+2.3%$48.81M$19.09MN/A90
FOCL
FocalTherics
3.6395 of 5 stars
$4.28
+5.2%
$7.75
+81.1%
N/A$160.63M$70.53MN/A230
ZJYL
Jin Medical International
0.9054 of 5 stars
$1.98
+0.5%
N/A-81.8%$155.30M$19.73MN/A273
CNXU
Conexeu Sciences
2.1942 of 5 stars
$5.30
+14.7%
$20.00
+277.4%
N/A$149.51MN/AN/A4
KRMD
KORU Medical Systems
3.7308 of 5 stars
$3.22
+0.6%
$7.00
+117.4%
-22.4%$147.90M$41.13MN/A73

Related Companies and Tools


This page (NASDAQ:POCI) was last updated on 9/22/2026 by MarketBeat.com Staff.
From Our Partners